The Liver Meeting 2024 - Debrief Sessions - Spanish-Hepatitis Debrief Session

Video Transcription

Video Summary

Dr. Tatiana Kushner, an Associate Professor at Weill Cornell School of Medicine, presented the hepatitis debrief focusing on recent developments in viral hepatitis. Key highlights included the approval of a new point-of-care test for hepatitis C and new universal screening recommendations for hepatitis B in the U.S. Key studies discussed explored treatments for hepatitis B, with one focusing on pediatric patients showing promising outcomes with pegylated interferon combined therapy. Hepatitis B and delta treatments using new therapeutics show promising results, indicating progress towards functional cures. Among treatments highlighted was bolivirutide, with positive long-term outcomes for patients with Delta hepatitis. For Hepatitis C, the potential for elimination efforts were discussed, with studies emphasizing the need for improved accessibility and implementation of rapid treatment programs. The treatment of Hepatitis C in pregnant individuals showed 100% SVR rates in interim study results, suggesting significant progress in addressing this final frontier patient population.

Keywords

viral hepatitis

hepatitis C

hepatitis B

pegylated interferon

bolivirutide

universal screening